Copyright
©2013 Baishideng Publishing Group Co.
World J Immunol. Jul 27, 2013; 3(2): 18-30
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Neuropathy syndrome | Antibody target | Antibody isotype |
Chronic Sensory-Motor demyelinating | Myelin-associated glycoprotein Sulfoglucuronylparagloboside | IgM (monoclonal) |
Chronic ataxic neuropathy | GD1b, GQ1b | IgM (monoclonal) |
Multifocal Motor neuropathy | GM1, GM2, GD1b | IgM (polyclonal or monoclonal) |
Sensory neuropathy | Sulfatide | IgM (monoclonal or polyclonal) |
Acute motor axonal neuropathy | GM1, GD1a, GalNAc GD1a, GM1b | IgG |
Acute inflammatory demyelinating polyneuropathy | Variable | Variable |
Miller-Fisher syndrome | GQ1b ("anti-GQ1b antibody syndrome"), GT1a | IgG |
Bickerstaff's brainstem encephalitis | ||
Acute ophthalmoparesis | ||
Ataxic Guillain-Barré syndrome | ||
Pharyngeal-cervical-brachial weakness | GT1a (GQ1b) | IgG |
Amyotrophic lateral sclerosis | GM1 | IgG |
- Citation: Maher J. Role of the clinical immunology laboratory in disease monitoring. World J Immunol 2013; 3(2): 18-30
- URL: https://www.wjgnet.com/2219-2824/full/v3/i2/18.htm
- DOI: https://dx.doi.org/10.5411/wji.v3.i2.18